MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 52 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -40.0% | 1,200 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -37.5% | 1,200 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -27.3% | 1,200 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -21.4% | 1,200 | 0.0% | 0.00% | – |
| Q1 2021 | $14,000 | +55.6% | 1,200 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +12.5% | 1,200 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 1,200 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +28.6% | 1,200 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -61.1% | 1,200 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | -25.0% | 1,200 | -50.0% | 0.00% | – |
| Q3 2019 | $24,000 | +41.2% | 2,400 | +100.0% | 0.00% | – |
| Q2 2019 | $17,000 | -10.5% | 1,200 | 0.0% | 0.00% | – |
| Q1 2019 | $19,000 | +216.7% | 1,200 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -57.1% | 1,200 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
| TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
| Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
| Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
| Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
| Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
| Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |